Dr. Jastreboff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St, PO Box 208020
Yale University School Of Medicine - Endocrinology
New Haven, CT 06510Phone+1 203-737-1932
Summary
- Dr. Jastreboff is an Associate Professor at Yale University School of Medicine. She is board certified in Obesity Medicine, adult Endocrinology and Metabolism, and Pediatric Endocrinology. She is nationally/internationally recognized in the Obesity Medicine field for developing Clinical Practice Guidelines (2016) for The Comprehensive Care of Patients with Obesity (AACE/ACE), educating the next generation of Obesity Medicine physicians by teaching annually at the world renowned Harvard Blackburn Treating Obesity course and the Columbia/Cornell Obesity course, and conducting cutting-edge clinical translational obesity research. Her research includes both large, multi-center clinical outcomes trials using anti-obesity medication as well as neuroimaging studies (fMRI and PET) examining the neurobiology underlying obesity and the mechanisms of anti-obesity medications.
Clinically, Dr. Jastreboff specializes in sophisticated use of anti-obesity medication combinations to help patients reach their weight and health goals. She mainly sees patients for obesity treatment and weight management.
Dr. Jastreboff completed her PhD at Yale University's Investigative Medicine Program focused on translational and clinical investigation with a dissertation entitled “Neural Response to Food Cues and Stress in Individuals with Obesity".
Dr. Jastreboff's research has been supported by NIH/NIDDK (K23, R01), American Diabetes Association (ADA), and industry funded multi-center clinical trials.
Education & Training
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2011
- University of MarylandResidency, Internal Medicine/Pediatrics, 2002 - 2006
- University of Maryland School of MedicineClass of 2002
Certifications & Licensure
- CT State Medical License 2010 - 2025
- MD State Medical License 2006 - 2008
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Glycemic Index of Commonly Consumed Sweeteners Start of enrollment: 2016 Oct 01
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity. Start of enrollment: 2018 Jun 06
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight Start of enrollment: 2021 Feb 01
Publications & Presentations
PubMed
- 85 citationsRetatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, ph...Julio Rosenstock, Juan Frias, Ania M Jastreboff, Yu Du, Jitong Lou
Lancet. 2023-08-12 - 161 citationsTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.Ania M Jastreboff, Lee M Kaplan, Juan P Frías, Qiwei Wu, Yu Du
The New England Journal of Medicine. 2023-08-10 - 106 citationsTirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 ...W Timothy Garvey, Juan P Frias, Ania M Jastreboff, Carel W le Roux, Naveed Sattar
Lancet. 2023-08-19
Press Mentions
- Tirzepatide Linked to Significant Weight Loss, ‘Impressive’ Diabetes Prevention After 3 YearsNovember 14th, 2024
- Zepbound's Weight Loss, Cardiometabolic Benefits Hold up at 3 YearsNovember 7th, 2024
- What Will Happen if I Stop Taking the New Weight-Loss Drugs After Losing Weight?August 9th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: